FIGURE 5.
NM23-H1 inhibits motility and invasive capacities of 1205LU melanoma cells in a manner independent of its 3’–5’ exonuclease, NDPK and histidine kinase activities. (a) The 1205LU panel of cell lines were evaluated for motility and (b) invasive characteristics in Boyden chamber assays. Asterisks denote means that are significantly different (p < 0.05) from all other treatment means within a panel, as determined by one-way ANOVA and Student’s t-Test.